GlassScriptPhysician profile
Gerald Andrew Helms
NPI 1346282928
$5,834.47
in general payments reported to CMS, 2019-2025
20 companies · $57.22 in 2025
The $57.22 reported for 2025 was less than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
See the full distribution for Thoracic Surgery (Cardiothoracic Vascular Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $985 · 2020: $68.62 · 2022: $2,229 · 2023: $1,643 · 2024: $852 · 2025: $57.22.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,425 · Travel and Lodging: $1,127.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,424.88 |
| Travel and Lodging | $1,127.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $4,547.76 | 2019-2024 | Da Vinci Surgical System |
| E.R. Squibb & Sons, L.L.C. | $472.63 | 2019-2022 | |
| Siemens Medical Solutions USA, INC. | $138.49 | 2024 | |
| Becton, Dickinson and Company | $123.47 | 2023 | Progel Applicator Spray Tips |
| Astrazeneca Pharmaceuticals LP | $113.57 | 2019-2025 | Tagrisso, Lynparza |
| Atricure, INC. | $70.01 | 2022-2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $46.87 | 2019 | |
| Tesaro, INC. | $41.27 | 2019 | |
| Ethicon US, LLC | $38.52 | 2022-2023 | Echelon Flex, Echelon Endopath |
| Takeda Pharmaceuticals U.S.A., INC. | $36.68 | 2019-2020 | |
| Pharmacyclics LLC, An Abbvie Company | $33.66 | 2019 | |
| Merck Sharp & Dohme LLC | $27.89 | 2019-2024 | Keytruda |
| Puma Biotechnology, INC. | $23.74 | 2019 | |
| Davol INC. | $22.79 | 2020 | |
| Janssen Biotech, INC. | $21.00 | 2025 | Rybrevant |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $19.04 | 2019 | |
| Sanofi-Aventis U.S. LLC | $17.19 | 2020 | |
| Seagen INC. | $14.71 | 2019 | |
| Abbvie INC. | $13.94 | 2019 | |
| Covidien LP | $11.24 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gerald Helms listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.